MissionIR's  Instablog

MissionIR
Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
MissionIR
My blog:
MissionIR Blog
  • Cardium Therapeutics, Inc. (CXM) Strategic Business Model Employs Diverse Product Lineup 0 comments
    Nov 12, 2013 5:32 PM | about stocks: CXM

    Cardium Therapeutics is a health sciences and regenerative medicine company strategizing to acquire and develop new and innovative bio-medical product opportunities that have definable pathways to commercialization, partnering, sale, or other economic monetizations. To avoid the risk of relying on the success of any single technology platform or product type, Cardium operates under a business model that allows for multiple opportunities and revenue channels.

    Excellagen® is the company's lead commercial product - a topical gel for wound care management with FDA clearance for marketing and sale in the United States. Excellagen is used for the treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds, and is intended for professional use following standard debridement procedures in the presence of blood cells and platelets, which are involved with the release of endogenous growth factors.

    Cardium's lead clinical development product candidate, Generx®, is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. Generx is designed to stimulate the growth of supplemental collateral blood vessels in the heart in order to enhance myocardial blood flow. Generx has progressed through four randomized, placebo-controlled clinical studies at more than 100 medical centers in the United States and Western Europe.

    To Go Brands, acquired in October 2012, develops, markets, and sells dietary supplements through established regional and national retailers. The brand markets and sells a portfolio of more than 25 products including, nutraceutical powder mixes, supplements, and chews to support healthy lifestyles.

    For more information, visit cardiumthx.com

    MissionIR provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit http://disclaimer.missionir.com

    Stocks: CXM
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.